Dr

Nikola Mićić

,

Associate
T:
+381 11 4127 070
M:
E:
nikola.micic@rspartners.rs
No items found.
Areas of Expertise

Corporate

Employment

Commercial Law

Education

LLB – Faculty of Law, University of Belgrade (2023)

Expertise

Nikola is an associate with a primary focus on corporate and M&A, employment and commercial matters.

Nikola joined Radovanović Stojanović & Partners after graduating from the University of Belgrade, where he obtained his LLB degree.

Publications
Admissions
Recognitions
Languages

Serbian, English, German

Memberships
*Independent attorney at law in cooperation with Radovanović Stojanović & Partners.

Related Insights

Rejection of Roche/ADOC exclusivity exemption: A sign of a stricter approach of the Serbian competition authority?
Legal Blog

Rejection of Roche/ADOC exclusivity exemption: A sign of a stricter approach of the Serbian competition authority?

The Serbian Commission for Protection of Competition (CPC) has denied Roche and ADOC's request to extend their exclusive distribution agreement exemption, marking a significant shift in regulatory oversight. This July 2024 decision affects the distribution of three crucial pharmaceuticals: Kadcyla, Perjeta, and Tecentriq.
Raško Radovanović
October 23, 2024
•
Radovanović Stojanović & Partners advises British American Tobacco on the sidestream merger of its Serbian subsidiaries
Legal Blog

Radovanović Stojanović & Partners advises British American Tobacco on the sidestream merger of its Serbian subsidiaries

Radovanović Stojanović & Partners advised British American Tobacco on a sidestream merger of its Serbian subsidiaries British American Tobacco South-East Europe doo Beograd (as the transferring entity) and British American Tobacco Vranje ad (as the surviving entity).
RS Partners
August 22, 2024
•